University of Turin at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University of Turin takes part in 8 sessions at ESMO 2026 in Madrid. Its program spans lung cancer, from extensive-stage small cell disease to immunotherapy before and after surgery in non-small cell lung cancer, and RAS biology. Other sessions cover predictors of vorasidenib response in IDH-mutant glioma, myeloma, cancer therapy in older patients and a biomarker for soft tissue sarcoma.
| Organization | ESMO 2026 Attendance |
|---|---|
University of Turin Turin, Italy | |
Public university in Turin, Italy, with a school of medicine and a molecular biotechnology research centre. | Abstract Fri Oct 23 13:30–13:35 Chair Sat Oct 24 08:30–10:00 Proffered Paper: Haematological malignancies Haematological malignancies Chair Sat Oct 24 12:00–12:50 ESMO-EACR: What oncologists should know about molecular oncology Biomarkers & precision oncology Talk Sat Oct 24 12:00–12:15 RAS biology Biomarkers & precision oncology Satellite Sat Oct 24 18:30–18:45 At a pivotal time: Where we stand today Lung & thoracic cancers Satellite Sat Oct 24 18:30–20:00 PharmaMar - More time for patients: Reframing the course of ES-SCLC Lung & thoracic cancers Talk Sun Oct 25 08:50–09:10 Novel approaches challenging the role of transplantation in the treatment of front-line myeloma Haematological malignancies Satellite Sun Oct 25 13:00–14:30 Satellite Sun Oct 25 13:00–13:05 Welcome and Introductions Lung & thoracic cancers Satellite Sun Oct 25 13:20–14:05 Neoadjuvant vs Perioperative Immunotherapy: An Expert Clinical Debate Lung & thoracic cancers Satellite Sun Oct 25 14:25–14:30 Close Lung & thoracic cancers Chair Mon Oct 26 08:30–10:00 Talk Mon Oct 26 08:55–09:20 Abstract Mon Oct 26 09:02–09:07 |
Instantly find 20 buyers from University of Turin
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction